ArticleFrontiers in psychology2026
Impact of chronic comorbidities on psychological and social status in COVID-19 patients.
Article in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the psychological and social status in patients with COVID-19 accompanied by common chronic diseases compared to patients without these chronic conditions. Additionally, the study aims to explore the relevant influencing factors, providing objective data and scientific theoretical basis for the psychological status of COVID-19 patients with common chronic diseases and improvement of their quality of life. Methods: Sixty patients diagnosed with COVID-19 and admitted to the Department of Respiratory and Critical Care Medicine in Fujian Medical University Union Hospital, between January 1, 2023, and March 31, 2023, were enrolled. The Hospital Anxiety and Depression Scale (HADS), Medical Coping Modes Questionnaire (MCMQ), Social Support Rating Scale (SSRS), and Type D Personality Scale (Ds-14) were used for the investigation. Admission complete blood count, blood biochemistry, and C-reactive protein (CRP) data were collected to calculate the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and C-reactive protein-to-albumin ratio (CAR). The prevalence of anxiety and depression was compared between patients with COVID-19 accompanied by chronic diseases and those without, and coping styles, social support, Type D personality, and CAR were analyzed and compared between the two groups. Results: Among 60 COVID-19 patients, 46 had accompanying chronic diseases, 14 patients had no accompanying chronic diseases. Patients with chronic diseases had higher anxiety and depression scores than those without. Moreover, there were statistically significant differences between the two groups in MCMQ, SSRS, and CAR ( Conclusion: The presence of common chronic diseases significantly influenced the coping styles and social support profiles of COVID-19 patients. Different psychosocial factors were associated with the occurrence and severity scores of anxiety and depression in patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.